Ex2 For prolonged surgical procedures, succinylcholincheloride is given by i.v. infusion for sustained muscle relaxation. A typical initial dose is 20 mg followed by continuous infusion of 4 mg/min. The infusion must be individualized because of variation in the kinetics of metabolism of succinylcholine. Estimate the elimination half-lives of suc- cinylcholine in patients requiring 0.4 mg/min and 4 mg/min, respectively, to maintain 20 mg in the body
Answer
When reach a steaty state, the elimination rate constant can be calculate using the equation \[A_{ss} = \frac{R_0}{k}\], and we have \[ k = \frac{R_0}{A_{ss}}\] then base on this equation to calculat t half-life \[t_{1/2} = \frac{ln2}{k}\]
options(digits = 2)
ex2_Ass <- 20 # mg
ex2_R01 <- 0.4 #mg/min
ex2_R02 <- 4 # mg/min
# when R0 = 0.4
ex2_k1 <- ex2_R01 / ex2_Ass
ex2_t1 <- log(2)/ ex2_k1
# when R0 = 4
ex2_k2 <- ex2_R02 / ex2_Ass
ex2_t2 <- log(2) / ex2_k2
- when R0 = 0.4 mg/min, t1/2 = 34.66 min.
- when R0 = 4 mg/min, t1/2 = 3.47 min.
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